These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 34712772)

  • 1. Comparison between Amulet and Watchman left atrial appendage closure devices: A real-world, single center experience.
    Saad M; Risha O; Sano M; Fink T; Heeger CH; Vogler J; Sciacca V; Eitel C; Stiermaier T; Joost A; Keelani A; Fuernau G; Meyer-Saraei R; Kuck KH; Eitel I; Richard Tilz R
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100893. PubMed ID: 34712772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of percutaneous Watchman 2.5 device versus Amplatzer Amulet for left atrial appendage closure in patients with non-valvular atrial fibrillation: A systematic review and study-level meta-analysis.
    Yasmin F; Ali E; Moeed A; Zaidi F; Umar M; Virwani V
    PLoS One; 2024; 19(2):e0295804. PubMed ID: 38354181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short term outcome after left atrial appendage occlusion with the AMPLATZER Amulet and WATCHMAN device: results from the ORIGINAL registry (saxOnian RegIstry analyzinG and followINg left atrial Appendage cLosure).
    Kretzler L; Mues C; Wunderlich C; Langbein A; Spitzer SG; Gerk U; Schellong S; Ketteler T; Neuser H; Schwefer M; Strasser R; Ibrahim K; Schoen S; Christoph M
    BMC Cardiovasc Disord; 2022 Jun; 22(1):271. PubMed ID: 35710343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study-level meta-analysis of clinical trials.
    Bing S; Chen RR
    Clin Cardiol; 2023 Feb; 46(2):117-125. PubMed ID: 36448417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Qiao J; Zhang B; Wang J; Pan L; Cheng T; Wang Y; Xiong E
    Cardiology; 2022; 147(3):290-297. PubMed ID: 35468598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis.
    Takeda K; Tsuboko Y; Iwasaki K
    Cardiovasc Interv Ther; 2022 Oct; 37(4):725-738. PubMed ID: 35098478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices.
    Mansour MJ; Harnay E; Al Ayouby A; Mansourati V; Jobic Y; Gilard M; Le Ven F; Mansourati J
    J Interv Card Electrophysiol; 2022 Jun; 64(1):27-34. PubMed ID: 34002319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort Study.
    Kayvanpour E; Kothe M; Kaya Z; Pleger S; Frey N; Meder B; Sedaghat-Hamedani F
    J Cardiovasc Dev Dis; 2024 May; 11(6):. PubMed ID: 38921657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of the Amplatzer Amulet and Watchman 2.5 for left atrial appendage occlusion: A systematic review and meta-analysis.
    Zhu MZ; Song H; Song GM; Bai X
    Pacing Clin Electrophysiol; 2022 Oct; 45(10):1237-1247. PubMed ID: 35933600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure.
    Kleinecke C; Cheikh-Ibrahim M; Schnupp S; Fankhauser M; Nietlispach F; Park JW; Brachmann J; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E324-E331. PubMed ID: 31631493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Closure with Watchman vs Amulet Devices: Similarities and Differences.
    Ahmed A; Bawa D; Kabra R; Pothineni NVK; Darden D; Gopinathannair R; Lakkireddy D
    Curr Cardiol Rep; 2023 Sep; 25(9):909-915. PubMed ID: 37584874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing safety and efficacy: MemoLefort versus watchman for left atrial appendage closure.
    Li L; Qian S; Fu JY; Wang ZN; Jiang T; Lin YN; Yao T; Liu JC; Pan YQ; Li YC
    Int J Cardiol; 2024 Mar; 398():131641. PubMed ID: 38065328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.